Latest updates for Mdckf
Fresh curated links around MDCKF are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- Merck KGaA (MKKGY) Q2 2026 Earnings Call Transcript
- medmix AG 2026 Q2 - Results - Earnings Call Presentation
- Chapters Group: Software Serial Acquirer And Possible Serial Compounder
Post angles to try
Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
seekingalpha.com
/1 month ago
Chapters Group: Software Serial Acquirer And Possible Serial Compounder
fiercebiotech.com
/1 month ago
Dimerix snaps up Mission’s stalled, phase 2-ready kidney disease candidate in $292M deal
Dimerix has bought an acute kidney injury drug from Mission Therapeutics, paying $5 million upfront and committing up to $287 million in milestones for the phase 2-ready asset.
seekingalpha.com
/1 month ago
Del Monte Corporation (DMC) Q2 2026 Earnings Call Transcript
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.
Sources covering Mdckf
seekingalpha.com
Recent coverage from public sources
Public source
fiercebiotech.com
Recent coverage from public sources
Public source